The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global 0.9% Sodium Chloride Intravenous Infusion Market Research Report 2024
Synopsis
0.9% sodium chloride water, also called as normal saline. It is a colorless, clear liquid. And it is sterile and no pyrogenic.
Global 0.9% Sodium Chloride Intravenous Infusion market is projected to reach US$ 1557.7 million in 2029, increasing from US$ 1241 million in 2022, with the CAGR of 3.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole 0.9% Sodium Chloride Intravenous Infusion market research.
The sodium chloride injection bag market is primarily driven by its essential role in intravenous (IV) fluid therapy, making it a critical medical device in healthcare settings. These bags contain sterile saline solution, used for hydration, electrolyte balance, and dilution of medications, indispensable in various medical procedures, surgeries, and emergency care. The increasing prevalence of conditions requiring IV fluid administration, such as dehydration, infections, and trauma, fuels the demand for sodium chloride injection bags. However, the market also faces challenges, including the rising concerns about plastic waste and environmental impact associated with single-use medical devices like IV bags. Manufacturers are actively exploring sustainable packaging options and eco-friendly materials to address these environmental challenges. Additionally, supply chain disruptions and fluctuations in the availability and cost of raw materials can impact the production and distribution of sodium chloride injection bags, posing challenges for healthcare facilities in ensuring a stable supply for patient care.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global 0.9% Sodium Chloride Intravenous Infusion market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Kelun Group
Baxter
Fresenius Kabi
Shijiazhuang No.4 Pharmaceutical
CR Double-Crane
B.Braun
Otsuka
Cisen Pharmaceutical
Hospira (ICU Medical)
Huaren Pharmaceuticals
Zhejiang Chimin
Dubang Pharmaceutical
Guizhou Tiandi
Qidu Pharmaceutical
Segment by Type
Flexible Bag
Plastic Bottles
Glass Bottle
Segment by Application
Hospitals
Clinics
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The 0.9% Sodium Chloride Intravenous Infusion report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
0.9% sodium chloride water, also called as normal saline. It is a colorless, clear liquid. And it is sterile and no pyrogenic.
Global 0.9% Sodium Chloride Intravenous Infusion market is projected to reach US$ 1557.7 million in 2029, increasing from US$ 1241 million in 2022, with the CAGR of 3.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole 0.9% Sodium Chloride Intravenous Infusion market research.
The sodium chloride injection bag market is primarily driven by its essential role in intravenous (IV) fluid therapy, making it a critical medical device in healthcare settings. These bags contain sterile saline solution, used for hydration, electrolyte balance, and dilution of medications, indispensable in various medical procedures, surgeries, and emergency care. The increasing prevalence of conditions requiring IV fluid administration, such as dehydration, infections, and trauma, fuels the demand for sodium chloride injection bags. However, the market also faces challenges, including the rising concerns about plastic waste and environmental impact associated with single-use medical devices like IV bags. Manufacturers are actively exploring sustainable packaging options and eco-friendly materials to address these environmental challenges. Additionally, supply chain disruptions and fluctuations in the availability and cost of raw materials can impact the production and distribution of sodium chloride injection bags, posing challenges for healthcare facilities in ensuring a stable supply for patient care.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global 0.9% Sodium Chloride Intravenous Infusion market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Kelun Group
Baxter
Fresenius Kabi
Shijiazhuang No.4 Pharmaceutical
CR Double-Crane
B.Braun
Otsuka
Cisen Pharmaceutical
Hospira (ICU Medical)
Huaren Pharmaceuticals
Zhejiang Chimin
Dubang Pharmaceutical
Guizhou Tiandi
Qidu Pharmaceutical
Segment by Type
Flexible Bag
Plastic Bottles
Glass Bottle
Segment by Application
Hospitals
Clinics
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The 0.9% Sodium Chloride Intravenous Infusion report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 0.9% Sodium Chloride Intravenous Infusion Market Overview
1.1 Product Overview and Scope of 0.9% Sodium Chloride Intravenous Infusion
1.2 0.9% Sodium Chloride Intravenous Infusion Segment by Type
1.2.1 Global 0.9% Sodium Chloride Intravenous Infusion Market Value Comparison by Type (2023-2029)
1.2.2 Flexible Bag
1.2.3 Plastic Bottles
1.2.4 Glass Bottle
1.3 0.9% Sodium Chloride Intravenous Infusion Segment by Application
1.3.1 Global 0.9% Sodium Chloride Intravenous Infusion Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global 0.9% Sodium Chloride Intravenous Infusion Market Size Estimates and Forecasts
1.4.1 Global 0.9% Sodium Chloride Intravenous Infusion Revenue 2018-2029
1.4.2 Global 0.9% Sodium Chloride Intravenous Infusion Sales 2018-2029
1.4.3 Global 0.9% Sodium Chloride Intravenous Infusion Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 0.9% Sodium Chloride Intravenous Infusion Market Competition by Manufacturers
2.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Manufacturers (2018-2023)
2.2 Global 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Manufacturers (2018-2023)
2.3 Global 0.9% Sodium Chloride Intravenous Infusion Average Price by Manufacturers (2018-2023)
2.4 Global 0.9% Sodium Chloride Intravenous Infusion Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of 0.9% Sodium Chloride Intravenous Infusion, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of 0.9% Sodium Chloride Intravenous Infusion, Product Type & Application
2.7 0.9% Sodium Chloride Intravenous Infusion Market Competitive Situation and Trends
2.7.1 0.9% Sodium Chloride Intravenous Infusion Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest 0.9% Sodium Chloride Intravenous Infusion Players Market Share by Revenue
2.7.3 Global 0.9% Sodium Chloride Intravenous Infusion Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 0.9% Sodium Chloride Intravenous Infusion Retrospective Market Scenario by Region
3.1 Global 0.9% Sodium Chloride Intravenous Infusion Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global 0.9% Sodium Chloride Intravenous Infusion Global 0.9% Sodium Chloride Intravenous Infusion Sales by Region: 2018-2029
3.2.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Region: 2018-2023
3.2.2 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Region: 2024-2029
3.3 Global 0.9% Sodium Chloride Intravenous Infusion Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Region: 2018-2029
3.3.1 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Region: 2018-2023
3.3.2 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Region: 2024-2029
3.4 North America 0.9% Sodium Chloride Intravenous Infusion Market Facts & Figures by Country
3.4.1 North America 0.9% Sodium Chloride Intravenous Infusion Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2018-2029)
3.4.3 North America 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe 0.9% Sodium Chloride Intravenous Infusion Market Facts & Figures by Country
3.5.1 Europe 0.9% Sodium Chloride Intravenous Infusion Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2018-2029)
3.5.3 Europe 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Market Facts & Figures by Country
3.6.1 Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2018-2029)
3.6.3 Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America 0.9% Sodium Chloride Intravenous Infusion Market Facts & Figures by Country
3.7.1 Latin America 0.9% Sodium Chloride Intravenous Infusion Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2018-2029)
3.7.3 Latin America 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Market Facts & Figures by Country
3.8.1 Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Sales by Country (2018-2029)
3.8.3 Middle East and Africa 0.9% Sodium Chloride Intravenous Infusion Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Type (2018-2029)
4.1.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Type (2018-2023)
4.1.2 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Type (2024-2029)
4.1.3 Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Type (2018-2029)
4.2 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Type (2018-2029)
4.2.1 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Type (2018-2023)
4.2.2 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Type (2024-2029)
4.2.3 Global 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Type (2018-2029)
4.3 Global 0.9% Sodium Chloride Intravenous Infusion Price by Type (2018-2029)
5 Segment by Application
5.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Application (2018-2029)
5.1.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Application (2018-2023)
5.1.2 Global 0.9% Sodium Chloride Intravenous Infusion Sales by Application (2024-2029)
5.1.3 Global 0.9% Sodium Chloride Intravenous Infusion Sales Market Share by Application (2018-2029)
5.2 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Application (2018-2029)
5.2.1 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Application (2018-2023)
5.2.2 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Application (2024-2029)
5.2.3 Global 0.9% Sodium Chloride Intravenous Infusion Revenue Market Share by Application (2018-2029)
5.3 Global 0.9% Sodium Chloride Intravenous Infusion Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Kelun Group
6.1.1 Kelun Group Corporation Information
6.1.2 Kelun Group Description and Business Overview
6.1.3 Kelun Group 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Kelun Group 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.1.5 Kelun Group Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Corporation Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Baxter 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Corporation Information
6.3.2 Fresenius Kabi Description and Business Overview
6.3.3 Fresenius Kabi 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Fresenius Kabi 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.3.5 Fresenius Kabi Recent Developments/Updates
6.4 Shijiazhuang No.4 Pharmaceutical
6.4.1 Shijiazhuang No.4 Pharmaceutical Corporation Information
6.4.2 Shijiazhuang No.4 Pharmaceutical Description and Business Overview
6.4.3 Shijiazhuang No.4 Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Shijiazhuang No.4 Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.4.5 Shijiazhuang No.4 Pharmaceutical Recent Developments/Updates
6.5 CR Double-Crane
6.5.1 CR Double-Crane Corporation Information
6.5.2 CR Double-Crane Description and Business Overview
6.5.3 CR Double-Crane 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2023)
6.5.4 CR Double-Crane 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.5.5 CR Double-Crane Recent Developments/Updates
6.6 B.Braun
6.6.1 B.Braun Corporation Information
6.6.2 B.Braun Description and Business Overview
6.6.3 B.Braun 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2023)
6.6.4 B.Braun 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.6.5 B.Braun Recent Developments/Updates
6.7 Otsuka
6.6.1 Otsuka Corporation Information
6.6.2 Otsuka Description and Business Overview
6.6.3 Otsuka 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Otsuka 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.7.5 Otsuka Recent Developments/Updates
6.8 Cisen Pharmaceutical
6.8.1 Cisen Pharmaceutical Corporation Information
6.8.2 Cisen Pharmaceutical Description and Business Overview
6.8.3 Cisen Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Cisen Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.8.5 Cisen Pharmaceutical Recent Developments/Updates
6.9 Hospira (ICU Medical)
6.9.1 Hospira (ICU Medical) Corporation Information
6.9.2 Hospira (ICU Medical) Description and Business Overview
6.9.3 Hospira (ICU Medical) 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Hospira (ICU Medical) 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.9.5 Hospira (ICU Medical) Recent Developments/Updates
6.10 Huaren Pharmaceuticals
6.10.1 Huaren Pharmaceuticals Corporation Information
6.10.2 Huaren Pharmaceuticals Description and Business Overview
6.10.3 Huaren Pharmaceuticals 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Huaren Pharmaceuticals 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.10.5 Huaren Pharmaceuticals Recent Developments/Updates
6.11 Zhejiang Chimin
6.11.1 Zhejiang Chimin Corporation Information
6.11.2 Zhejiang Chimin 0.9% Sodium Chloride Intravenous Infusion Description and Business Overview
6.11.3 Zhejiang Chimin 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Zhejiang Chimin 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.11.5 Zhejiang Chimin Recent Developments/Updates
6.12 Dubang Pharmaceutical
6.12.1 Dubang Pharmaceutical Corporation Information
6.12.2 Dubang Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Description and Business Overview
6.12.3 Dubang Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Dubang Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.12.5 Dubang Pharmaceutical Recent Developments/Updates
6.13 Guizhou Tiandi
6.13.1 Guizhou Tiandi Corporation Information
6.13.2 Guizhou Tiandi 0.9% Sodium Chloride Intravenous Infusion Description and Business Overview
6.13.3 Guizhou Tiandi 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Guizhou Tiandi 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.13.5 Guizhou Tiandi Recent Developments/Updates
6.14 Qidu Pharmaceutical
6.14.1 Qidu Pharmaceutical Corporation Information
6.14.2 Qidu Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Description and Business Overview
6.14.3 Qidu Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Qidu Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product Portfolio
6.14.5 Qidu Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 0.9% Sodium Chloride Intravenous Infusion Industry Chain Analysis
7.2 0.9% Sodium Chloride Intravenous Infusion Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 0.9% Sodium Chloride Intravenous Infusion Production Mode & Process
7.4 0.9% Sodium Chloride Intravenous Infusion Sales and Marketing
7.4.1 0.9% Sodium Chloride Intravenous Infusion Sales Channels
7.4.2 0.9% Sodium Chloride Intravenous Infusion Distributors
7.5 0.9% Sodium Chloride Intravenous Infusion Customers
8 0.9% Sodium Chloride Intravenous Infusion Market Dynamics
8.1 0.9% Sodium Chloride Intravenous Infusion Industry Trends
8.2 0.9% Sodium Chloride Intravenous Infusion Market Drivers
8.3 0.9% Sodium Chloride Intravenous Infusion Market Challenges
8.4 0.9% Sodium Chloride Intravenous Infusion Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
